Jonathan Lovell, associate professor
Department of Biomedical Engineering
An experimental flu vaccine consisting of billions of tiny spherical sacs that carry infection-fighting proteins throughout the body has proven effective in preclinical studies.
Described in a study published May 24 in the Proceedings of the National Academy of Sciences, the vaccine has the potential to:
Improve the effectiveness of seasonal flu vaccines, which typically work 40-60% of the time, according to the U.S. Centers for Disease Control and Prevention.
Take less time to produce large quantities because, unlike most seasonal flu vaccines, it is not created in embryonated chicken eggs.
Use smaller doses, thereby increasing vaccine supplies, which can be critical given the unpredictable nature of influenza.
Arts & Science
Follow U of T News
‘We need to prepare’: U of T’s Christine Allen on investing in biomanufacturing, life sciences research (Photo by Nick Iwanyshyn)
With an eye to supporting Canada’s pandemic recovery and preparing for future threats to public health, the federal government recently announced $2.2 billion in investment over seven years in the life sciences.
“These growing fields are not only critical to our safety, but are fast-growing sectors that support well-paying jobs and attract investment,” the budget document reads.
The investments are welcomed by the University of Toronto and will help the university to modernize critical lab infrastructure, support cutting-edge research and industry partnerships, and train the next generation of researchers, says
A research group from the University of Alberta has identified a new approach to use 3D bioprinting technology to make custom-shaped cartilage that can be used in surgical procedures.
New research, published today in Nature, models the impacts on the Antarctic Ice Sheet of several different global warming scenarios and the resulting.
Article content
Nose cartilage using 3D bioprinting that involves mixing a Jell-O-like material with cells harvested from a patient has been created by a University of Alberta team.
Skin cancer patients living with nasal cartilage defects post-surgery may soon be able to have features more safely restored now that the Edmonton team has, in just four weeks, cultured a material in a lab to become functional cartilage, said a Tuesday news release from the university.
We apologize, but this video has failed to load.
Try refreshing your browser, or 3-D bioprinting using cells, Jell-O like mix creates nose cartilage for patients: U of A team Back to video